Stèphane Califice

1.1k total citations
8 papers, 910 citations indexed

About

Stèphane Califice is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Stèphane Califice has authored 8 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Genetics. Recurrent topics in Stèphane Califice's work include Galectins and Cancer Biology (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Glioma Diagnosis and Treatment (3 papers). Stèphane Califice is often cited by papers focused on Galectins and Cancer Biology (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Glioma Diagnosis and Treatment (3 papers). Stèphane Califice collaborates with scholars based in Belgium, United States and Switzerland. Stèphane Califice's co-authors include Frédéric van den Brûle, Vincent Castronovo, Vincent Castronovo, V Castronovo, Marc Bracke, Andrew Berchuck, Pedro L. Fernández, Katja Bierau, Maria Artesi and Adelin Albert and has published in prestigious journals such as Oncogene, European Journal of Cancer and BMC Cancer.

In The Last Decade

Stèphane Califice

8 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stèphane Califice Belgium 7 591 546 210 195 141 8 910
Anantha Marisetty United States 11 323 0.5× 295 0.5× 236 1.1× 168 0.9× 168 1.2× 18 720
Cameron J. Herting United States 11 291 0.5× 500 0.9× 362 1.7× 244 1.3× 130 0.9× 18 862
Tyler Alban United States 15 307 0.5× 397 0.7× 255 1.2× 377 1.9× 163 1.2× 33 938
Klara Soukup Austria 10 299 0.5× 437 0.8× 316 1.5× 299 1.5× 127 0.9× 18 894
Jumpei Homma Japan 11 296 0.5× 307 0.6× 240 1.1× 306 1.6× 108 0.8× 15 725
Elin Ekström Sweden 5 514 0.9× 191 0.3× 137 0.7× 227 1.2× 288 2.0× 6 810
Stephanie Smith‐Berdan United States 13 473 0.8× 290 0.5× 102 0.5× 460 2.4× 186 1.3× 18 1.1k
Diego Carrera United States 5 305 0.5× 470 0.9× 386 1.8× 250 1.3× 219 1.6× 6 855
Jules Gadiot Netherlands 14 483 0.8× 461 0.8× 123 0.6× 641 3.3× 139 1.0× 21 1.1k
Mine Esencay United States 8 335 0.6× 252 0.5× 300 1.4× 361 1.9× 295 2.1× 10 861

Countries citing papers authored by Stèphane Califice

Since Specialization
Citations

This map shows the geographic impact of Stèphane Califice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stèphane Califice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stèphane Califice more than expected).

Fields of papers citing papers by Stèphane Califice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stèphane Califice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stèphane Califice. The network helps show where Stèphane Califice may publish in the future.

Co-authorship network of co-authors of Stèphane Califice

This figure shows the co-authorship network connecting the top 25 collaborators of Stèphane Califice. A scholar is included among the top collaborators of Stèphane Califice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stèphane Califice. Stèphane Califice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Robe, Pierre A., Didier Martin, Maria Artesi, et al.. (2009). Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer. 9(1). 372–372. 138 indexed citations
2.
Vlassenbroeck, Ilse, Stèphane Califice, Annie‐Claire Diserens, et al.. (2008). Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma. Journal of Molecular Diagnostics. 10(4). 332–337. 148 indexed citations
3.
Sadones, Jan, Alex Michotte, Pieter In 'T Veld, et al.. (2008). MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. European Journal of Cancer. 45(1). 146–153. 45 indexed citations
4.
Califice, Stèphane, Vincent Castronovo, Marc Bracke, & Frédéric van den Brûle. (2004). Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene. 23(45). 7527–7536. 155 indexed citations
5.
Califice, Stèphane, et al.. (2004). Galectin-3 and cancer (Review).. International Journal of Oncology. 25(4). 983–1075. 125 indexed citations
6.
Califice, Stèphane, et al.. (2004). [Prostate carcinoma cell lines and apoptosis: a review].. PubMed. 59(12). 704–10. 3 indexed citations
7.
8.
Brûle, Frédéric van den, Stèphane Califice, & Vincent Castronovo. (2002). Expression of galectins in cancer: A critical review. Glycoconjugate Journal. 19(7-9). 537–542. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anantha Marisetty Breakdown of academic impact, for papers by Cameron J. Herting Breakdown of academic impact, for papers by Tyler Alban Breakdown of academic impact, for papers by Klara Soukup Breakdown of academic impact, for papers by Jumpei Homma Breakdown of academic impact, for papers by Elin Ekström Breakdown of academic impact, for papers by Stephanie Smith‐Berdan Breakdown of academic impact, for papers by Diego Carrera Breakdown of academic impact, for papers by Jules Gadiot Breakdown of academic impact, for papers by Mine Esencay
Rankless by CCL
2026